Flputnam Investment Management Co. Has $2.17 Million Stock Holdings in Zoetis Inc. $ZTS

Key Points

• Flputnam Investment Management increased its Zoetis stake by 1,595.7% in the second quarter, holding 30,218 shares valued at approximately $2.17 million. Institutional investors collectively own 92.8% of Zoetis.
• Analyst sentiment is mixed, with eight Buy, nine Hold, and two Sell ratings; the stock carries a consensus Hold rating and an average price target of $107.43.
• Zoetis shares opened at $77.45, near their 52-week low of $71.00. The company slightly exceeded quarterly EPS expectations at $1.87, though revenue of $2.47 billion declined 0.2% year over year.

Flputnam Investment Management Co. lifted its stake in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 1,595.7% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 30,218 shares of the company's stock after purchasing an additional 28,436 shares during the quarter. Flputnam Investment Management Co.'s holdings in Zoetis were worth $2,171,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. BlackRock Inc. lifted its position in Zoetis by 10.8% during the second quarter. BlackRock Inc. now owns 39,430,181 shares of the company's stock worth $2,833,453,000 after purchasing an additional 3,845,869 shares during the period. J. Stern & Co. LLP increased its holdings in Zoetis by 12,431.2% in the 4th quarter. J. Stern & Co. LLP now owns 24,069,492 shares of the company's stock valued at $3,028,423,000 after buying an additional 23,877,416 shares during the period. State Street Corp raised its position in shares of Zoetis by 0.8% in the 4th quarter. State Street Corp now owns 19,796,891 shares of the company's stock valued at $2,490,845,000 after buying an additional 149,382 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Zoetis by 1.7% in the 4th quarter. Geode Capital Management LLC now owns 11,327,679 shares of the company's stock valued at $1,420,294,000 after buying an additional 189,235 shares in the last quarter. Finally, Deutsche Bank AG lifted its holdings in shares of Zoetis by 5.8% during the 2nd quarter. Deutsche Bank AG now owns 5,851,737 shares of the company's stock worth $420,506,000 after acquiring an additional 319,709 shares during the period. Institutional investors own 92.80% of the company's stock.

Analyst Upgrades and Downgrades

A number of brokerages have weighed in on ZTS. UBS Group reduced their target price on Zoetis from $85.00 to $80.00 and set a "neutral" rating on the stock in a report on Friday, August 7th. William Blair reissued a "market perform" rating on shares of Zoetis in a research note on Thursday, August 6th. BNP Paribas Exane dropped their price objective on shares of Zoetis from $146.00 to $110.00 and set an "outperform" rating for the company in a research note on Tuesday, August 11th. JPMorgan Chase & Co. lowered their price target on shares of Zoetis from $130.00 to $115.00 and set an "overweight" rating for the company in a report on Friday, August 7th. Finally, Barclays cut their price objective on Zoetis from $136.00 to $85.00 and set an "equal weight" rating on the stock in a report on Wednesday, July 1st. Eight analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have given a Sell rating to the company's stock. Based on data from MarketBeat.com, Zoetis has a consensus rating of "Hold" and an average price target of $107.43.

Zoetis Trading Up 0.1%

ZTS opened at $77.45 on Monday. The company has a debt-to-equity ratio of 2.87, a current ratio of 3.08 and a quick ratio of 1.84. Zoetis Inc. has a fifty-two week low of $71.00 and a fifty-two week high of $156.49. The company's 50 day moving average price is $75.57 and its two-hundred day moving average price is $95.40. The firm has a market capitalization of $32.00 billion, a price-to-earnings ratio of 12.76, a PEG ratio of 1.80 and a beta of 0.73.

Zoetis (NYSE:ZTS - Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The company reported $1.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.02. The firm had revenue of $2.47 billion during the quarter, compared to the consensus estimate of $2.50 billion. Zoetis had a net margin of 27.49% and a return on equity of 74.89%. The company's revenue for the quarter was down .2% on a year-over-year basis. During the same quarter last year, the firm earned $1.76 earnings per share. Zoetis has set its FY 2026 guidance at 6.150-6.250 EPS. As a group, research analysts predict that Zoetis Inc. will post 6.2 earnings per share for the current year.

Zoetis Profile

Zoetis Inc NYSE: ZTS is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company's offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source